title: Prognostic factors for 246 neonates with infections.
authors.forename: B M
authors.initials: BM
authors.lastname: Hafed
authors.forename: E
authors.initials: E
authors.lastname: Bilikova
authors.forename: G
authors.initials: G
authors.lastname: Kovacicova
authors.forename: J
authors.initials: J
authors.lastname: Koprnova
authors.forename: I
authors.initials: I
authors.lastname: Svetlansky
authors.forename: D
authors.initials: D
authors.lastname: Chovancova
authors.forename: M
authors.initials: M
authors.lastname: Huttova
authors.forename: V
authors.initials: V
authors.lastname: Krcmery
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001724:Birth Weight; D002511:Cephalosporins / Q000627:therapeutic use; D005865:Gestational Age; D006801:Humans; D016867:Immunocompromised Host; D007231:Infant, Newborn; D010406:Penicillins / Q000627:therapeutic use; D011379:Prognosis; D012307:Risk Factors; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010406:Penicillins